Table 3. Univariate and multivariate analyses of overall survival according to clinicopathological parameters and SPARC levels with 1000 bootstraping.
Characteristics | No | Uni–variant analysis | Multi–variant analysis | ||||||
---|---|---|---|---|---|---|---|---|---|
Patients | Events | HR | 95% CI | P–value | HR | 95% CI | P–value | Bootstrapping 95% CI | |
Age (years) | 137 | 71 | 1.011 | 0.988–1.034 | 0.368 | ||||
Gender | 1.124 | 0.635–1.988 | 0.689 | ||||||
Female | 34 | 15 | |||||||
Male | 103 | 56 | |||||||
Surgery D2 | 0.508 | 0.185–1.396 | 0.189 | 0.296 | 0.103–0.852 | 0.024 | 0.076–0.847 | ||
Yes | 131 | 67 | |||||||
No | 6 | 4 | |||||||
Location | 0.750 | 0.516–1.089 | 0.130 | ||||||
Fundus & cardia | 8 | 6 | |||||||
Body | 55 | 31 | |||||||
Antrum & pylous | 74 | 34 | |||||||
Differentiation | 1.047 | 0.655–1.675 | 0.847 | ||||||
Well & moderate | 62 | 33 | |||||||
Poor & mixed | 75 | 38 | |||||||
Lauren type | 1.627 | 0.998–2.650 | 0.051 | ||||||
Intestinal | 59 | 25 | |||||||
Diffused | 78 | 46 | |||||||
T stage | 2.769 | 1.313–5.837 | 0.007 | 3.032 | 1.394–6.594 | 0.005 | 1.608–8.174 | ||
T1–T3 | 29 | 8 | |||||||
T4 | 108 | 63 | |||||||
N stage | 3.917 | 1.692–9.067 | 0.001 | 3.866 | 1.664–8.982 | 0.002 | 1.865–10.979 | ||
N0 | 31 | 6 | |||||||
N1–N3 | 106 | 65 | |||||||
M stage | 1.409 | 0.431–4.609 | 0.571 | ||||||
M0 | 133 | 68 | |||||||
M1 | 4 | 3 | |||||||
SPARC expression | 1.798 | 1.080–2.995 | 0.024 | 1.835 | 1.093–3.083 | 0.022 | 1.179–3.401 | ||
Negative | 53 | 21 | |||||||
Positive | 84 | 50 |